Clinical Trials Browser

Phase 4 × OTHER_GOV × Other hematologic neoplasm × Clear all

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05133310 2022-01-04

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Phase 4 Unknown

Classical hematologyLymphoidOther hematologic neoplasm

Sprains and Strains, Sepsis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT03908138 2019-11-29

RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma

Phase 4 Unknown

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT01339988 2011-04-21

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Phase 4 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile